ArticleJournal for immunotherapy of cancer2023

Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.

Abdul Rafeh Naqash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.